nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivermectin—ABCC2—Spironolactone—dilated cardiomyopathy	0.348	0.42	CbGbCtD
Ivermectin—ABCC2—Furosemide—dilated cardiomyopathy	0.237	0.287	CbGbCtD
Ivermectin—ABCB1—Lisinopril—dilated cardiomyopathy	0.129	0.156	CbGbCtD
Ivermectin—ABCB1—Spironolactone—dilated cardiomyopathy	0.113	0.137	CbGbCtD
Ivermectin—Unspecified visual loss—Lisinopril—dilated cardiomyopathy	0.00946	0.0669	CcSEcCtD
Ivermectin—Apathy—Furosemide—dilated cardiomyopathy	0.00386	0.0272	CcSEcCtD
Ivermectin—Flat affect—Furosemide—dilated cardiomyopathy	0.00382	0.027	CcSEcCtD
Ivermectin—Lethargy—Spironolactone—dilated cardiomyopathy	0.00375	0.0265	CcSEcCtD
Ivermectin—Blindness—Lisinopril—dilated cardiomyopathy	0.00373	0.0264	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00331	0.0234	CcSEcCtD
Ivermectin—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00314	0.0222	CcSEcCtD
Ivermectin—Throat sore—Lisinopril—dilated cardiomyopathy	0.00287	0.0203	CcSEcCtD
Ivermectin—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00284	0.0201	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00281	0.0198	CcSEcCtD
Ivermectin—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0024	0.017	CcSEcCtD
Ivermectin—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00234	0.0165	CcSEcCtD
Ivermectin—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00227	0.0161	CcSEcCtD
Ivermectin—Lethargy—Furosemide—dilated cardiomyopathy	0.00204	0.0144	CcSEcCtD
Ivermectin—GLRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00201	0.0639	CbGpPWpGaD
Ivermectin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00198	0.014	CcSEcCtD
Ivermectin—GLRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00196	0.0621	CbGpPWpGaD
Ivermectin—NR1H4—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00195	0.0618	CbGpPWpGaD
Ivermectin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00186	0.0132	CcSEcCtD
Ivermectin—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00183	0.0129	CcSEcCtD
Ivermectin—Confusional state—Spironolactone—dilated cardiomyopathy	0.00182	0.0129	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.0018	0.0127	CcSEcCtD
Ivermectin—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00174	0.0123	CcSEcCtD
Ivermectin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00171	0.0121	CcSEcCtD
Ivermectin—Somnolence—Spironolactone—dilated cardiomyopathy	0.00161	0.0113	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00153	0.0108	CcSEcCtD
Ivermectin—NR1H4—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.00152	0.0482	CbGpPWpGaD
Ivermectin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00149	0.0105	CcSEcCtD
Ivermectin—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.00149	0.0472	CbGpPWpGaD
Ivermectin—Face oedema—Lisinopril—dilated cardiomyopathy	0.00145	0.0102	CcSEcCtD
Ivermectin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00143	0.0101	CcSEcCtD
Ivermectin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00143	0.0101	CcSEcCtD
Ivermectin—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00137	0.00968	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00135	0.00954	CcSEcCtD
Ivermectin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00133	0.0094	CcSEcCtD
Ivermectin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00131	0.00924	CcSEcCtD
Ivermectin—Asthma—Lisinopril—dilated cardiomyopathy	0.0013	0.00916	CcSEcCtD
Ivermectin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00128	0.00907	CcSEcCtD
Ivermectin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00128	0.00903	CcSEcCtD
Ivermectin—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00126	0.00892	CcSEcCtD
Ivermectin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00124	0.00873	CcSEcCtD
Ivermectin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00119	0.00844	CcSEcCtD
Ivermectin—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00118	0.0375	CbGpPWpGaD
Ivermectin—ABCC1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00117	0.0371	CbGpPWpGaD
Ivermectin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00115	0.00811	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00115	0.0081	CcSEcCtD
Ivermectin—Rash—Spironolactone—dilated cardiomyopathy	0.00114	0.00804	CcSEcCtD
Ivermectin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00114	0.00804	CcSEcCtD
Ivermectin—Headache—Spironolactone—dilated cardiomyopathy	0.00113	0.00799	CcSEcCtD
Ivermectin—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—dilated cardiomyopathy	0.00113	0.0359	CbGpPWpGaD
Ivermectin—Anaemia—Furosemide—dilated cardiomyopathy	0.00111	0.00786	CcSEcCtD
Ivermectin—Haematuria—Lisinopril—dilated cardiomyopathy	0.0011	0.00779	CcSEcCtD
Ivermectin—Vertigo—Furosemide—dilated cardiomyopathy	0.00108	0.00764	CcSEcCtD
Ivermectin—Leukopenia—Furosemide—dilated cardiomyopathy	0.00108	0.00761	CcSEcCtD
Ivermectin—Nausea—Spironolactone—dilated cardiomyopathy	0.00107	0.00758	CcSEcCtD
Ivermectin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00104	0.00733	CcSEcCtD
Ivermectin—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00102	0.0325	CbGpPWpGaD
Ivermectin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00102	0.00722	CcSEcCtD
Ivermectin—Confusional state—Furosemide—dilated cardiomyopathy	0.000991	0.007	CcSEcCtD
Ivermectin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000981	0.00693	CcSEcCtD
Ivermectin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00095	0.00671	CcSEcCtD
Ivermectin—Anorexia—Furosemide—dilated cardiomyopathy	0.000937	0.00662	CcSEcCtD
Ivermectin—Chills—Lisinopril—dilated cardiomyopathy	0.000931	0.00658	CcSEcCtD
Ivermectin—Hypotension—Furosemide—dilated cardiomyopathy	0.000918	0.00649	CcSEcCtD
Ivermectin—Back pain—Lisinopril—dilated cardiomyopathy	0.000874	0.00617	CcSEcCtD
Ivermectin—Somnolence—Furosemide—dilated cardiomyopathy	0.000874	0.00617	CcSEcCtD
Ivermectin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000854	0.00603	CcSEcCtD
Ivermectin—Fatigue—Furosemide—dilated cardiomyopathy	0.000847	0.00598	CcSEcCtD
Ivermectin—Tremor—Lisinopril—dilated cardiomyopathy	0.000846	0.00598	CcSEcCtD
Ivermectin—Constipation—Furosemide—dilated cardiomyopathy	0.00084	0.00594	CcSEcCtD
Ivermectin—Pain—Furosemide—dilated cardiomyopathy	0.00084	0.00594	CcSEcCtD
Ivermectin—Anaemia—Lisinopril—dilated cardiomyopathy	0.000835	0.0059	CcSEcCtD
Ivermectin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000812	0.00573	CcSEcCtD
Ivermectin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00081	0.00572	CcSEcCtD
Ivermectin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000809	0.00571	CcSEcCtD
Ivermectin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000803	0.00568	CcSEcCtD
Ivermectin—Cough—Lisinopril—dilated cardiomyopathy	0.000788	0.00557	CcSEcCtD
Ivermectin—Urticaria—Furosemide—dilated cardiomyopathy	0.000781	0.00551	CcSEcCtD
Ivermectin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000777	0.00549	CcSEcCtD
Ivermectin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000777	0.00549	CcSEcCtD
Ivermectin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000769	0.00543	CcSEcCtD
Ivermectin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000769	0.00543	CcSEcCtD
Ivermectin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000769	0.00543	CcSEcCtD
Ivermectin—Discomfort—Lisinopril—dilated cardiomyopathy	0.00076	0.00537	CcSEcCtD
Ivermectin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000743	0.00525	CcSEcCtD
Ivermectin—Oedema—Lisinopril—dilated cardiomyopathy	0.000737	0.00521	CcSEcCtD
Ivermectin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000724	0.00511	CcSEcCtD
Ivermectin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00072	0.00508	CcSEcCtD
Ivermectin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000713	0.00504	CcSEcCtD
Ivermectin—Asthenia—Furosemide—dilated cardiomyopathy	0.000705	0.00498	CcSEcCtD
Ivermectin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000703	0.00496	CcSEcCtD
Ivermectin—GLRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0007	0.0222	CbGpPWpGaD
Ivermectin—Pruritus—Furosemide—dilated cardiomyopathy	0.000695	0.00491	CcSEcCtD
Ivermectin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000689	0.00487	CcSEcCtD
Ivermectin—GLRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000681	0.0216	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000681	0.0216	CbGpPWpGaD
Ivermectin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000672	0.00475	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000672	0.00475	CcSEcCtD
Ivermectin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000657	0.00464	CcSEcCtD
Ivermectin—Somnolence—Lisinopril—dilated cardiomyopathy	0.000655	0.00463	CcSEcCtD
Ivermectin—Dizziness—Furosemide—dilated cardiomyopathy	0.00065	0.00459	CcSEcCtD
Ivermectin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000641	0.00453	CcSEcCtD
Ivermectin—ABCC1—S1P1 pathway—RAC1—dilated cardiomyopathy	0.000641	0.0203	CbGpPWpGaD
Ivermectin—Fatigue—Lisinopril—dilated cardiomyopathy	0.000636	0.00449	CcSEcCtD
Ivermectin—GLRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000633	0.0201	CbGpPWpGaD
Ivermectin—Pain—Lisinopril—dilated cardiomyopathy	0.00063	0.00445	CcSEcCtD
Ivermectin—Constipation—Lisinopril—dilated cardiomyopathy	0.00063	0.00445	CcSEcCtD
Ivermectin—Vomiting—Furosemide—dilated cardiomyopathy	0.000625	0.00441	CcSEcCtD
Ivermectin—Rash—Furosemide—dilated cardiomyopathy	0.00062	0.00438	CcSEcCtD
Ivermectin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000619	0.00437	CcSEcCtD
Ivermectin—Headache—Furosemide—dilated cardiomyopathy	0.000616	0.00435	CcSEcCtD
Ivermectin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000608	0.00429	CcSEcCtD
Ivermectin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000603	0.00426	CcSEcCtD
Ivermectin—Urticaria—Lisinopril—dilated cardiomyopathy	0.000586	0.00414	CcSEcCtD
Ivermectin—Nausea—Furosemide—dilated cardiomyopathy	0.000584	0.00412	CcSEcCtD
Ivermectin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000583	0.00412	CcSEcCtD
Ivermectin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000583	0.00412	CcSEcCtD
Ivermectin—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000556	0.0176	CbGpPWpGaD
Ivermectin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000543	0.00384	CcSEcCtD
Ivermectin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000529	0.00374	CcSEcCtD
Ivermectin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000522	0.00368	CcSEcCtD
Ivermectin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000504	0.00356	CcSEcCtD
Ivermectin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000488	0.00344	CcSEcCtD
Ivermectin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000469	0.00331	CcSEcCtD
Ivermectin—Rash—Lisinopril—dilated cardiomyopathy	0.000465	0.00328	CcSEcCtD
Ivermectin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000464	0.00328	CcSEcCtD
Ivermectin—Headache—Lisinopril—dilated cardiomyopathy	0.000462	0.00326	CcSEcCtD
Ivermectin—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.000442	0.014	CbGpPWpGaD
Ivermectin—Nausea—Lisinopril—dilated cardiomyopathy	0.000438	0.00309	CcSEcCtD
Ivermectin—GABRB3—Ion channel transport—RYR2—dilated cardiomyopathy	0.000428	0.0136	CbGpPWpGaD
Ivermectin—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000417	0.0133	CbGpPWpGaD
Ivermectin—GABRB3—Ion channel transport—PLN—dilated cardiomyopathy	0.000417	0.0132	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000408	0.0129	CbGpPWpGaD
Ivermectin—GLRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000397	0.0126	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000383	0.0122	CbGpPWpGaD
Ivermectin—NR1H4—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000342	0.0108	CbGpPWpGaD
Ivermectin—NR1H4—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000336	0.0107	CbGpPWpGaD
Ivermectin—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000334	0.0106	CbGpPWpGaD
Ivermectin—ABCC1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000322	0.0102	CbGpPWpGaD
Ivermectin—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000314	0.00996	CbGpPWpGaD
Ivermectin—NR1H4—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000308	0.00977	CbGpPWpGaD
Ivermectin—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000301	0.00956	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000276	0.00877	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000269	0.00853	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000269	0.00853	CbGpPWpGaD
Ivermectin—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000251	0.00796	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00025	0.00793	CbGpPWpGaD
Ivermectin—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00024	0.00764	CbGpPWpGaD
Ivermectin—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00023	0.00731	CbGpPWpGaD
Ivermectin—NR1H4—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000211	0.0067	CbGpPWpGaD
Ivermectin—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000207	0.00659	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000199	0.00632	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000187	0.00595	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000182	0.00577	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—TAZ—dilated cardiomyopathy	0.000171	0.00542	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—NR3C2—dilated cardiomyopathy	0.000162	0.00514	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000157	0.00499	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000155	0.00492	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—SDHA—dilated cardiomyopathy	0.000154	0.0049	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000149	0.00473	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000145	0.00461	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000145	0.00461	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00014	0.00445	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000138	0.00439	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000137	0.00434	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000135	0.00428	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000135	0.00428	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000133	0.00422	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000133	0.00422	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000132	0.0042	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000131	0.00417	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000131	0.00417	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000123	0.00392	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000122	0.00387	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000119	0.00377	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000115	0.00367	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000115	0.00367	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000111	0.00352	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000107	0.00341	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000103	0.00327	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—NPPA—dilated cardiomyopathy	0.000102	0.00323	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	9.94e-05	0.00316	CbGpPWpGaD
Ivermectin—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	9.5e-05	0.00302	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.42e-05	0.00299	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	9.29e-05	0.00295	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.17e-05	0.00291	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	8.87e-05	0.00282	CbGpPWpGaD
Ivermectin—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	8.45e-05	0.00268	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	8.34e-05	0.00265	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.26e-05	0.00262	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	7.8e-05	0.00248	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	7.54e-05	0.00239	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	7.34e-05	0.00233	CbGpPWpGaD
Ivermectin—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.14e-05	0.00227	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	6.64e-05	0.00211	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.42e-05	0.00204	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.24e-05	0.00198	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.24e-05	0.00198	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.8e-05	0.00184	CbGpPWpGaD
Ivermectin—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	5.47e-05	0.00174	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.45e-05	0.00173	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	5.09e-05	0.00162	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.91e-05	0.00156	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.81e-05	0.00153	CbGpPWpGaD
Ivermectin—ABCC1—Disease—NPPA—dilated cardiomyopathy	4.61e-05	0.00146	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.6e-05	0.00146	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.48e-05	0.00142	CbGpPWpGaD
Ivermectin—ABCC1—Disease—PSEN2—dilated cardiomyopathy	4.46e-05	0.00142	CbGpPWpGaD
Ivermectin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	4.22e-05	0.00134	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	4.22e-05	0.00134	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—GPX1—dilated cardiomyopathy	4.19e-05	0.00133	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—CD36—dilated cardiomyopathy	4.08e-05	0.0013	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.03e-05	0.00128	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.97e-05	0.00126	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—AGT—dilated cardiomyopathy	3.68e-05	0.00117	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	3.59e-05	0.00114	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.19e-05	0.00101	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.94e-05	0.000934	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.69e-05	0.000855	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.66e-05	0.000845	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.6e-05	0.000825	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.44e-05	0.000776	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.34e-05	0.000744	CbGpPWpGaD
Ivermectin—ABCC1—Disease—RAC1—dilated cardiomyopathy	2.24e-05	0.000713	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.21e-05	0.000702	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.19e-05	0.000694	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.08e-05	0.000661	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	2.05e-05	0.000651	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—CD36—dilated cardiomyopathy	1.99e-05	0.000634	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	1.8e-05	0.000572	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—AGT—dilated cardiomyopathy	1.8e-05	0.00057	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—CD36—dilated cardiomyopathy	1.76e-05	0.000557	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—AGT—dilated cardiomyopathy	1.58e-05	0.000502	CbGpPWpGaD
Ivermectin—ABCC1—Disease—RAF1—dilated cardiomyopathy	1.49e-05	0.000473	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.27e-05	0.000402	CbGpPWpGaD
Ivermectin—ABCC1—Disease—EGFR—dilated cardiomyopathy	1.02e-05	0.000324	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	9.74e-06	0.000309	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	9.49e-06	0.000301	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	8.55e-06	0.000271	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	6e-06	0.000191	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.85e-06	0.000186	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.26e-06	0.000167	CbGpPWpGaD
